Trial Profile
British study of risedronate [risedronic acid] in structure and symptoms of knee osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Feb 2010
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms BRISK
- 23 Feb 2006 New trial record.